U.S.-Israel research foundation backs Cigna collaboration

BY Matt Pilon

A U.S.-Israel foundation has awarded funding Cigna and an Israeli maker of a wrist blood oxygen sensor to collaborate on a digital care platform.

The Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation on Thursday announced $6.3 million in grants to be shared among seven different collaborations, the rest of which involve companies outside of Connecticut. It wasn't immediately clear Friday morning exactly how much money Cigna's project with Oxitone Medical received.

Representatives of Oxitone visited Hartford late last year as part of an Israeli delegation of companies that visited with area health and insurance executives and gathered at Upward Hartford.

Oxitone says its wrist blood oxygen sensor is the first to be approved by the U.S. Food & Drug Administration.

BIRD was formed in 1977 and has since provided grants as high as $1 million to more than 950 projects.